4//SEC Filing
Q Therapeutics, Inc. 4
Accession 0001209191-14-020462
CIK 0001366541operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:23 PM ET
Size
7.8 KB
Accession
0001209191-14-020462
Insider Transaction Report
Form 4
Q Therapeutics, Inc.[NONE]
GREBOW PETER E
Director
Transactions
- Award
Option to Purchase Common Stock
2014-03-11$0.70/sh+50,000$35,000→ 125,000 totalExercise: $0.70From: 2014-03-11Exp: 2024-03-10→ Common Stock (50,000 underlying) - Award
Option to Purchase Common Stock
2014-03-11$0.70/sh+50,000$35,000→ 125,000 totalExercise: $0.70From: 2014-03-11Exp: 2024-03-10→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Grant relates to 2013 director compensation and is considered immediately vested.
- [F2]Grant relates to 2014 director compensation, and 8,333 options vest immediately with the remaining balance vesting in equal increments over the next ten months.
Documents
Issuer
Q Therapeutics, Inc.
CIK 0001366541
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001366541
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:23 PM ET
- Size
- 7.8 KB